Skip to main content
. 2020 Jul 1;66(8):855–861. doi: 10.1097/MAT.0000000000001209

Table 3.

Costs

Event Cost ($) References
LVAD implantation 154,565*
LVAD monthly outpatient 3,187 16
MM monthly outpatient 3,515 16
Living with LVAD > 10 years—annual 18,377†
Living on MM > 10 years—annual 9,005†
Heart transplantation 154,565*
Living after HT—annual 16,807‡
Stroke
 First 90 days 27,904‡
 Follow-up 19
  mRS 0—monthly 956
  mRS 1—monthly 984
  mRS 2—monthly 1,138
  mRS 3—monthly 1,955
  mRS 4—monthly 3,956
  mRS 5—monthly 5,816*
Pump exchange 154,565*
Driveline infection 13,681‡
GI bleed 9,990‡
RVAD 78,676§
Other adverse events 9,220‡
MM readmission (apart from stroke) 12,934 16

All costs were adjusted to reflect 2018 prices either on the IHD platform or using the medical care–specific CPI from the Bureau of Labor Statistics.20

*CMS 2019 DRGs (i.e., 91.5% DRG 001 and 8.5% DRG 002).

†DRG 291 for cost estimation; event rate post 18-month resource use in Smedira.30

‡Medicare claims analysis.

§CMS 2019 DRG 215.

LVAD, left ventricular assist device; MM, medical management; HT, heart transplantation; mRS, modified Rankin Scale; GI, gastrointestinal; RVAD, right ventricular assist device.